jump to content jump to footer

RACOON FADEN Project Tackles Early Detection of Adenomyosis

Endometriosis is a vastly under-researched condition affecting women, but it is finally receiving the attention it deserves through the RACOON FADEN project.

In an insightful interview, Prof. Dr. Sylvia Mechsner (Charité Berlin) and Prof. Dr. Matthias May (University Hospital Erlangen) discuss the RACOON FADEN project, which focuses on the early detection of adenomyosis, a form of endometriosis.

This project addresses a critical gap in the diagnosis and treatment of women with severe menstrual pain. The study uses MRI scans to detect early signs of adenomyosis and gain a deeper understanding of the morphology of a healthy uterus. Additionally, the interview highlights the innovative use of structured reporting and the existing RACOON infrastructure to enhance diagnostic precision and accelerate research.

Read the full interview here.

Success Story Interview Clinical Research Standardized Reading Procedures MRI Interoperability Personalized Therapy RACOON AI Structured Reporting

Related Resources

mint Lesion usage during a clinical trial read, featuring the TGRM export tool.
Bridging the Gap Between RECIST and Survival: Why the FDA’s Analysis of the g Value is a Game-Changer

For decades, oncology trials have relied on RECIST 1.1 to evaluate drug efficacy. However, these categorical "snapshot" evaluations do not always…

Participants at the RECIST and Beyond workshop in Cologne during hands-on training with mint Lesion for structured tumor response assessment.
The two-day “RECIST and Beyond” workshop at radCIO Cologne offered intensive hands-on training on RECIST, iRECIST, mRECIST and LI-RADS, with real-case reporting performed directly in mint Lesion.
Successful “RECIST and Beyond” Workshop in Cologne: Advancing Precision in Oncologic Imaging

How can complex tumor findings be assessed accurately, reproducibly, and in line with clinical guidelines?

Screenshot of the mint Lesion interface showing RANO 2.0 configuration, tumor burden calculations, and structured neuro-oncology assessment tools.
mint Lesion fully supports RANO 2.0 implementation with configurable parameters, automated tumor burden calculations, and structured workflows for neuro-oncology clinical trials.
Implementing RANO 2.0 for Neuro-Oncology Clinical Trials in mint Lesion

Tumor response assessment in neuro-oncology clinical trials requires careful attention to measurement protocols and confirmation scan requirements. To…